A further mechanism causing MYCN aberrant activation can be mediated by the hot spot mutation c.131C>T (p.Pro44Leu) initially identified in neuroblastoma as an acquired somatic event with predicted gain of function [20]. This evidence concerns the gene MYCN and neuroblastoma.